The concentrations of free fatty acids in plasma were estimated in thirty-three subjects, before and after (24 hours and 72 hours) the Start of bromazepam oral administration in a daily dose of 6 mg (1.5 mg at 7 a.m., l .5 mg at 3 p.m. and 3 mg at 11 p.m.). A fourth estimation was performed 72 hours after drug discontinuation. A control group of twelve subjects received aplacebo according to the same dosage pattern.
Introduction
The influence of the central nervous System (CNS) on lipid metabolism and particularly, on free fatty acid mobilization is indisputable. |ts exact mechanism, howê ver. remains to be clarified.
The concentration of free fatty acids in plasma is generally accepted äs a sensitive measure of CNS arousal (1) (2) (3) (4) (5) (6) .
The purpose of the present study is to examine the possible influence of a known CNS-acting drug, the tranquillizer bromazepam, on the concentration of free fatty acids in human plasma. Such an influence would constitute indirect evidence of CNS regulation of the mobilization of free fatty acids in man, mainly through the hypothalamus and limbic System.
Materials and Methods
Patients Thirty-thrce subjects, hospitalizcd for a ciinical and laboratory investigation, were selected for the apparent absence of any organic disease; this disease-free Status was later confirmed. To minimisc any possible distress from the hospitalization itself, the subjects were studied betwecn the 2nd and 3rd day after admission. All of them were in a 12-hour state of fasting during the Papagcorgion. Lcvis. Kondou and Moulopoulos: Frcc fatty acids, ccntral nctvous System and bromazcpam four morning pcriods of observation. There was no tobacco. coffoe or tea consumption. No subject was receiving medication, and all subjocts were resting without excrcisc. The womcn, still in reproiluetive agc, were studied between the lOth and 20th day of thcir mcnstrual eycle. The venipunctures were all purformcd by the samc physician. \vhcn thc paticnt was still in bed, just aftcr awakening, and thc tourniquct application did not excccd 60 scconds. Thc administered tranquillizer was thc bcnzodiazcpinc, bromazcpam (Lcxotan® <Rochc», administcred orally. I-our samples were takcn from cacli subject. namcly:
1. Bcforc drug administration. U. 24 hours after thc first administration of the drug (6 mg/ 24 h in doscs of 1 .5 mg at 7 a. m., 1 .5 mg at 3 p.m. and 3 mgat 11 p.m.). 111. 72 hours aftcr the first administration of thc drug, with thc samc dosage pattcrn s above. IV. 72 hours after drug discontinuation. It was not possiblc to completc thc study for all subjects, becausc somc of thcm left the hospital carlier than anticipated. Anothcr group of subjccts (12 cascs) was uscd s a control group. These subjects, which wcre selected under thc samc conditions, wcrc given placebo tabicts according to thc above dosage pattcrn.
Mcthod
Blood was collccted into an heparinizcd syringc a t the various time intervals stated above, cooled at 4 °C, and ccntrifuged for 10 min at 3000 min" 1 . Thc plasma was separated immcdiatcly aftcr collcction and deep frozcn at -20 °C for later analysis. Plasma free fatty acids were estimatcd in duplicate by the mcthod ofDucombe using 0.2 ml of plasma (7) . For this purposc thc rcagcnt kit No 126055 of Boehringcr Mannheim GmbH and palmitic acid Standard were used. Thc quality of the assay was estimatcd by mcasuring 10 rcplicatc samples of two plasma pools (0.16 and 0.38 mmol/1). In accordance with a previous report (8) the intraassay coefflcicnt of Variation was lower than 5.0%. All samples of each patient wcre detcrmined together in thc samc run immcdiately after the end of the test period. Thc results arc givcn s thc mean of duplicate samples. Statistical comparison between the four samples of cach subjcct was madc by the t-pair test. II versus the I cstimation).
Results

Comparison bet\veen values I and U (tab. l)
The free fatty acid concentrations in the first samples (before drug administration) ranged from 125 μπιοΐ/ΐ to 815 μηιοΐ/ΐ plasma (mean value 422 ± 29.5 SEM Mmol/l), i.e. within normal limits, except for five cases which were a little above the upper lim it.
Values for the free fatty acid concentration of the second samples (24 h after beginning of drug administration) ranged from 110 μιηοΐ/ΐ to 780 μηιοΐ/ΐ plasma (mean value 363 ± 25 SEM μπιοΐ/ΐ), i.e. within normal limits, only one case being slightly above the upper limit.
Values for the second samples were found to be significantly lower than those for the first samples (p < 0.05 using the t-pair statistical analysis). In 24 out of 33 cases the values obtained were decreased from 2.9% to 58.3% with a mean value of 23.7 ±3.4 SEM %.
In three eases a small increase was noted (mean value: 4.13 ± l .27 SEM %). In four cases an increase was noted (mean value: 14.9 ± l .0 SEM %), whereas in two extreme cases rather large increases were noted (38% and 112.7%).
Comparison between values IandIII (tab. 2)
In 29 cases out of the initial 33, where a third sample was available (72 hours after Initiation of drug adrnini-7 stration), the free fatty acid concentrations were also within normal limits, ranging between 98 μίηοΐ/ΐ and 808 μιποΐ/ΐ plasma (mean value: 353 ± 31 SEM μπκ>1/1). Three cases were a little higher. In all 29 cases the free fatty acid concentrations in· the plasma were significantly lower (p < 0.05) in III than in I, using the t-pair test.
In 20 cases the observed decrease ranged from 9.1% to 67.1 % (rnean vahie: 27.8 ± 2.8 SEM %), in four cases Analytically, on 9 out of the 12 members of the control group, the free fatty acid concentrations showed a percentage increase between the first and the second estimation ranging from 5.5% to 77.2% (mean value: 36.9 ± 9.4 SEM %) while in the remaining 3 cases the values were decreased by 9.7% to 39.7% (mean value: 22.4 ±8.9 SEM %).
In 9 out of the 12 cases the values between the first and the third measurement were increased (5.8% to 91.1 %, mean value: 44.6 ± 9.4 SEM %) and in 3 cases decreased (4.9% to 20.4%, mean value: 13.2 ± 4.5 SEM %). Group U: 7 cases wherc the observed values wcre incrcascd in cslimalion II and then decreascd ( fig. 2) . In 5 cases llic decrease was in estimation III, and in 2 cases in estimation IV. In othcr words, the frec fatty acitl values of this group-also evcntually show a decrease.
I.il» 4 r<;c f jüy acitl uincentf Jtion valuct fpmol/1 plauna) of patients bcfore (I), 24 h HD* 72 h (111) after the first drugadministraiion and 72 h .lilt-r drup diurintimution f IV) and relative ehanges in control group 2 case»
Group C: This compriscs 6 cases where the decrease in estimation II is followcd by an incrcase in estimation III ( fig. 3) . Briefiy, in 18 out of 33 cases the conccntration of free fatty acids in plasma werc dccreased in all estimations, under dirug influencc. In 14 out of the remaining 15 cases there was a decrease in one or two estimations, and in one case only all the values wcre a littlc increased with respcct to estimation I.
In contrast, there is no statisticaJ correlation (p > 0.05) between the obtained values in the control group, after placebo administration ( fig. 6 ).
Discussion
The results obtained, in all but one case, show a statistically significant decrease (p < 0.05 to p < 0.001) of the concentrations of free fatty acids in plasma. with respect to those before treatment.
The above-mentioned decrease in concentrations of free fatty acids in plasma has the characteristic of being observed after 24 h administration and persists after the 72 hours of administration (p < 0.05) äs well äs 72 hours after bromazepam discontinuation (p < 0.001).
A lot of research work, during the last years, refers to the CNS infiuence on the mobilization of free fatty acids (l -5,9). The exact mechanism of such an infiuence is still unsettled, since the clinical studies äs well äs the experimcntal ones have lead to various hypotheses äs to the direct or indirect infiuence of the CNS on lipid metabolism. 11 has been shown that electrical Stimulation of the hypothalamus causes a prompt elevation of the concentration of free fatty acids in plasma (10). Sapira et al. (11) found significant elevation in plasma free fatty acids, after psychological Stimulation in volunteers. It is of intcrest to emphasize the gradual diminution of this reaction after the adaptation to the Stimulus (12) . Similar studies, clinical or experimentaJ, show that any CNS Stimulation, physical (9, 10, 13) or psychological (1, 4, 14) , results in plasma free fatty acid elevation. On the other band, peripheral blockade of the syrnpathetic "autonomic" nervous System by means of adrenergie or ganglionic blocking agents, inhibits the Physiologie response of increased free fatty acids after threatening Stimuli (5, (15) (16) (17) (18) . Experimental studies on animals pr ve the necessity of the peripheral nerve integrity in order to maintain an equilibrium in lipid metabolism (19) . This is probably due to the function of the autonomic routes of the nerve. Therefore, in case of nerve section, transmission of eiferen t autonomic impulses, chiefly from the hypothalamus, is interrupted.
It is generally accepted that the action of the nervous System upon free fatty acids is exerted by means of a complicated humoral mechanism (20) , This includes a considcrable number of hormones and peptides, which contribute in maintaining a complex dynamic equilibrium, by either cnhancing or inhibiting each other in various proportions (21). The substances known tö be active in lipid mobilization, from adipose tissue, include adrenal steroids, glucagon, somatostatin, endo hins and enkephalins (22) and the hypophyseal honnones vasopressin, thyrotropin, corticotropin, prolactin, somatotropin and the (3-and 7-lipotropins (20) , but the most important hormones regulating lipolysis are the neural and circulating catecholamines. The increase of catecholamines results in the elevation of the concentration of free fatty acids in plasma. The main pathway of catecholamine action on lipolysis is believed to be through the activation of adenylate cyclase, leading to an increased level of cAMP, which leads to phosphorylation and activation of triglyceride lipase. It seems likely that other pathway s of catecholamine lipolysis, non cAMP-dependent, may also exist but their exact action remains unclear äs yet (23).
On the other hand, it is well-known that the catecholamine plasma concentration is elevated during the state of "stress" which rfcsults form the arousal of CNS (17) .
Thus the concentration of free fatty acids in plasma expresses one of the biochemical parameters of "stress".
Many investigators (9, 24-27) have worked on the response of free fatty acid concentrations in plasma to the administration of tranquillizers acting on the CNS. These studies were either performed on experimental animals or the tranquillizer was administered after induced hyperlipidaemia (26) or experimental neural Stimulation. In these studies the estimation of free fatty acids was performed only after a single dose of the drug under investigation. Thus a comparison of our results with those concerning other benzodiazepines is not possible, because in the present study the administration of the tranquillizer is constant and of a long duration, imitating the usual clinical administration. This kind of administration plus the pharmacokinetic properties of bromazepam (half-life . time 21-24 h, regulär elimination due to the absence of other active metabolites) (28) limits the role of interindividual variations of plasma bromazepam concentrations. In addition, the timing of estimations of free fatty acid concentration in plasma, äs already described, examines both the cumulative phase and the steady state of bromazepam plasma concentration. Througjiout this "steady state" phase intrasubject fluctuations were limited to a large extent.
The presence of active bromazepäm plasma concentrations during the drug administfation was judged by the clinical appearance of the patients i.e. theif behavioural arousal level. They were slightly somfiolent, whereas before the first dose they were normally wake. Finally the opinion that benzodiazepmes exert a direct action on the releasing rate of free fatty acids fröm adipose tissue is excluded by the results of in vitro studies (9) . We consider that OUT findings are more relevant to the true action of the drug, because the significänt decrease of free fatty acids was observed in individüals under normal conditions, without a previous deviation of their neural or metabolic functions. Furthermore, continuous drug administration represents a more constant action on the concentration of free fatty acids in plasma and is closer to the routine practice, where the tranquillizer is not administered in a single dose. In conclusion. our findings constitüte one more indication that CNS Inhibition causes a decisive control over lipid mobilization, reducing the concentration of free fatty acids in plasma.
